Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEDAPLATIN for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where NEDAPLATIN was used for Neoplasm.

Most Reported Side Effects for NEDAPLATIN

Side Effect Reports % Deaths Hosp.
Myelosuppression 272 36.9% 9 151
White blood cell count decreased 61 8.3% 0 27
Thrombocytopenia 51 6.9% 9 7
Off label use 49 6.6% 2 20
Neutropenia 45 6.1% 5 3
Neutrophil count decreased 41 5.6% 0 15
Bone marrow failure 35 4.7% 4 10
Gastrointestinal disorder 35 4.7% 1 4
Platelet count decreased 35 4.7% 0 15
Disease progression 33 4.5% 14 3
Nausea 30 4.1% 4 6
Anaemia 29 3.9% 6 11
Febrile neutropenia 27 3.7% 10 6
Diarrhoea 26 3.5% 6 7
Vomiting 26 3.5% 3 5

Other Indications for NEDAPLATIN

Oesophageal carcinoma (92) Lung neoplasm malignant (71) Nasopharyngeal cancer (46) Chemotherapy (36) Cervix carcinoma (28) Germ cell cancer (25) Lung adenocarcinoma (25) Ovarian cancer (20) Oesophageal squamous cell carcinoma (17) Metastases to lymph nodes (15)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

NEDAPLATIN Full Profile All Neoplasm Drugs NEDAPLATIN Demographics NEDAPLATIN Timeline